Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01115699 · ClinicalTrials.gov registry record · NA

Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as Adjuvant Treatment for Depression

A NA study, sponsored by Mayo Clinic.

Terminated
Registry status
NA
Development phase
2
Enrollment target

NCT01115699: Clinical Trial NA study, sponsored by Mayo Clinic.

NCT01115699 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01115699, a NA study, was terminated before completion, sponsored by Mayo Clinic.

TERMINATED
Registry status
NA
Development phase
2 participants
Enrollment target

Study Summary

The study will systematically investigate the use of repetitive transcranial magnetic stimulation (rTMS) in non-remitters of a selective serotonin reuptake inhibitor (SSRI) followed by a serotonin-norepinephrine reuptake inhibitor (SNRI) trial with the capacity to identify gene variants that predict rTMS response.

Primary Outcome

The HRS-D17 questionnaire has 17 items. Each item on the questionnaire is scored on a 3 or 5 point scale, depending on the item. A score of 0-7 is considered to be normal. Scores of 20 or higher indicate moderate, severe, or very severe depression.

Interventions

  • DEVICE Repetitive Transcranial Magnetic Stimulation (rTMS)

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2010-04
Est. Completion 2012-03
Phase NA
Mayo Clinic

2,844 total trials

Why NCT01115699 stopped before completion

NCT01115699 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Repetitive Transcranial Magnetic Stimulation (rTMS) is the first listed.

NCT01115699 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01115699 about?

NCT01115699 is a clinical study titled "Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as Adjuvant Treatment for Depression". The study will systematically investigate the use of repetitive transcranial magnetic stimulation (rTMS) in non-remitters of a selective serotonin reuptake inhibitor (SSRI) followed by a serotonin-norepinephrine reuptake inhibitor (SNRI) trial with the capacity to identify gene variants that predict...

What is the current status of trial NCT01115699?

This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2010-04. Estimated completion is 2012-03.

What interventions are being tested in trial NCT01115699?

The interventions under investigation include: Repetitive Transcranial Magnetic Stimulation (rTMS) (DEVICE).

Who is sponsoring clinical trial NCT01115699?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01115699's enrollment target sits among peer trials

2 1997th of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01115699, the US trial registry maintained by the National Library of Medicine. NCT01115699 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.